HK1053066A1 - New (aminopropyl) methylphosphinic acids. - Google Patents

New (aminopropyl) methylphosphinic acids.

Info

Publication number
HK1053066A1
HK1053066A1 HK03105476A HK03105476A HK1053066A1 HK 1053066 A1 HK1053066 A1 HK 1053066A1 HK 03105476 A HK03105476 A HK 03105476A HK 03105476 A HK03105476 A HK 03105476A HK 1053066 A1 HK1053066 A1 HK 1053066A1
Authority
HK
Hong Kong
Prior art keywords
aminopropyl
new
methylphosphinic
acids
methylphosphinic acids
Prior art date
Application number
HK03105476A
Other languages
English (en)
Inventor
Kosrat Amin
Thomas Elebring
Peter Guzzo
Thomas Olsson
Marianne Swanson
Sverker Von Unge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1053066A1 publication Critical patent/HK1053066A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03105476A 1999-12-09 2003-07-29 New (aminopropyl) methylphosphinic acids. HK1053066A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904507A SE9904507D0 (sv) 1999-12-09 1999-12-09 New compounds
PCT/SE2000/002427 WO2001041743A1 (en) 1999-12-09 2000-12-04 New (aminopropyl)methylphosphinic acids

Publications (1)

Publication Number Publication Date
HK1053066A1 true HK1053066A1 (en) 2003-10-10

Family

ID=20418062

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03105476A HK1053066A1 (en) 1999-12-09 2003-07-29 New (aminopropyl) methylphosphinic acids.

Country Status (27)

Country Link
US (1) US6596711B1 (xx)
EP (1) EP1239843A1 (xx)
JP (1) JP2003516346A (xx)
KR (1) KR100752010B1 (xx)
CN (1) CN1200713C (xx)
AR (1) AR033350A1 (xx)
AU (1) AU780259B2 (xx)
BR (1) BR0016291A (xx)
CA (1) CA2393510A1 (xx)
CO (1) CO5261538A1 (xx)
CZ (1) CZ20021984A3 (xx)
EE (1) EE200200287A (xx)
HK (1) HK1053066A1 (xx)
HU (1) HUP0300386A3 (xx)
IL (2) IL150090A0 (xx)
IS (1) IS6409A (xx)
MX (1) MXPA02005537A (xx)
NO (1) NO20022729L (xx)
NZ (1) NZ519377A (xx)
PL (1) PL357115A1 (xx)
RU (1) RU2267495C2 (xx)
SE (1) SE9904507D0 (xx)
SK (1) SK7632002A3 (xx)
TW (1) TWI225415B (xx)
UA (1) UA73149C2 (xx)
WO (1) WO2001041743A1 (xx)
ZA (1) ZA200204122B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
TW200407110A (en) * 2001-11-23 2004-05-16 Astrazeneca Ab New use for the treatment of gastroesophageal reflux disease
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
DE10305463A1 (de) * 2003-02-04 2004-08-12 Schering Ag Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
CA2632016A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
EP1968947A1 (en) 2005-12-23 2008-09-17 AstraZeneca AB Gaba-b receptor modulators
EP2155762B1 (en) * 2007-05-04 2011-10-12 AstraZeneca AB Process for the synthesis of alkyl phosphinic acids by initiation of an amine and an amineoxide
JP2010534239A (ja) * 2007-07-25 2010-11-04 アストラゼネカ・アクチエボラーグ Ｎｅｒｄの治療のための（３−アミノ−２−フルオロプロピル）ホスフィン酸の使用
PE20091310A1 (es) * 2007-12-21 2009-09-30 Astrazeneca Ab Nueva forma cristalina b del acido (2r)-(3-amino-2-fluoropropil)fosfinico
PE20091311A1 (es) * 2007-12-21 2009-09-30 Astrazeneca Ab Nuevo proceso para preparar la forma a del acido (2r)-(3-amino-2-fluoropropil)fosfinico
JP2011026260A (ja) * 2009-07-28 2011-02-10 Central Glass Co Ltd ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en) 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
EP0250572A1 (en) 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
GB8820266D0 (en) 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
FR2663934B1 (fr) 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
FR2722192A1 (fr) 1994-07-06 1996-01-12 Adir Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en) 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
SE9603408D0 (sv) 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
AR033350A1 (es) 2003-12-17
CN1200713C (zh) 2005-05-11
CO5261538A1 (es) 2003-03-31
US6596711B1 (en) 2003-07-22
KR100752010B1 (ko) 2007-08-28
AU2241201A (en) 2001-06-18
IL150090A (en) 2006-08-01
EE200200287A (et) 2003-08-15
IS6409A (is) 2002-06-06
HUP0300386A2 (hu) 2003-07-28
AU780259B2 (en) 2005-03-10
NZ519377A (en) 2003-11-28
BR0016291A (pt) 2002-08-13
JP2003516346A (ja) 2003-05-13
SK7632002A3 (en) 2003-03-04
RU2002113916A (ru) 2004-01-10
CZ20021984A3 (cs) 2002-11-13
TWI225415B (en) 2004-12-21
ZA200204122B (en) 2003-10-29
CN1413104A (zh) 2003-04-23
WO2001041743A1 (en) 2001-06-14
RU2267495C2 (ru) 2006-01-10
KR20020060993A (ko) 2002-07-19
EP1239843A1 (en) 2002-09-18
CA2393510A1 (en) 2001-06-14
IL150090A0 (en) 2002-12-01
MXPA02005537A (es) 2004-09-10
SE9904507D0 (sv) 1999-12-09
PL357115A1 (en) 2004-07-12
NO20022729L (no) 2002-07-09
NO20022729D0 (no) 2002-06-07
UA73149C2 (en) 2005-06-15
HUP0300386A3 (en) 2005-08-29

Similar Documents

Publication Publication Date Title
HK1048321A1 (en) New aminopropylphosphinic acids.
AP2006003492A0 (en) Azaindoles.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
HK1051199A1 (en) New phenylpiperazines.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200108968B (en) New compounds.
ZA200204122B (en) New (aminopropyl)methylphosphinic acids.
ZA200200300B (en) Substituted phenoxyacetic acids.
MXPA03002090A (es) °-tio-aminoacidos.
MXPA02000261A (es) Aminoindanos novedosos.
HK1032679A1 (en) Connector.
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.
GB2353949B (en) Figurine
ZA200005361B (en) Positioning arrangement.
CA92102S (en) Figurine
GB9913845D0 (en) The bouncy shoe
GB9904668D0 (en) Glyphosate fprmulation
GB9902981D0 (en) The publicans friend
SI1317426T1 (sl) Beta-tio-aminokisline
ZA200109011B (en) New Process.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091204